No Data
Sana Biotechnology: Strong Buy Rating Amidst Promising Pipeline and Solid Financials
Sana Biotechnology Price Target Cut to $11.00/Share From $12.00 by HC Wainwright & Co.
Sana Biotechnology Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Sana Biotechnology, Lowers Price Target to $11
Sana Biotechnology Analyst Ratings
Sana Biotechnology Rises 6% as Data From Several Studies Will Be Released by Year-end